Wrapmanager Inc. Has $282,000 Stake in Sanofi (NASDAQ:SNY)

Wrapmanager Inc. reduced its holdings in shares of Sanofi (NASDAQ:SNY) by 32.7% in the 4th quarter, HoldingsChannel.com reports. The fund owned 5,662 shares of the company’s stock after selling 2,750 shares during the quarter. Wrapmanager Inc.’s holdings in Sanofi were worth $282,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Rise Advisors LLC boosted its stake in Sanofi by 98.4% in the 4th quarter. Rise Advisors LLC now owns 506 shares of the company’s stock valued at $25,000 after purchasing an additional 251 shares during the period. Salem Investment Counselors Inc. acquired a new position in shares of Sanofi in the fourth quarter valued at about $27,000. Venturi Wealth Management LLC increased its position in Sanofi by 163.5% during the fourth quarter. Venturi Wealth Management LLC now owns 535 shares of the company’s stock worth $27,000 after acquiring an additional 332 shares during the period. McIlrath & Eck LLC increased its position in Sanofi by 143.3% during the fourth quarter. McIlrath & Eck LLC now owns 613 shares of the company’s stock worth $30,000 after acquiring an additional 361 shares during the period. Finally, CNB Bank acquired a new stake in Sanofi in the 3rd quarter worth about $39,000. 10.04% of the stock is owned by institutional investors and hedge funds.

Sanofi Price Performance

Shares of Sanofi stock traded down $1.41 on Thursday, reaching $48.69. 1,121,985 shares of the stock were exchanged, compared to its average volume of 2,003,665. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.87 and a current ratio of 1.27. The firm has a market cap of $123.17 billion, a PE ratio of 24.47, a P/E/G ratio of 1.37 and a beta of 0.61. The firm’s 50 day moving average is $47.99 and its 200-day moving average is $48.13. Sanofi has a one year low of $42.63 and a one year high of $55.72.

Sanofi Increases Dividend

The firm also recently announced an annual dividend, which will be paid on Thursday, June 6th. Shareholders of record on Friday, May 10th will be issued a $1.478 dividend. This represents a dividend yield of 2.98%. The ex-dividend date is Thursday, May 9th. This is an increase from Sanofi’s previous annual dividend of $1.38. Sanofi’s dividend payout ratio (DPR) is currently 69.35%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. StockNews.com lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, February 27th. Morgan Stanley began coverage on Sanofi in a research report on Tuesday, January 23rd. They set an “equal weight” rating and a $55.00 price target on the stock. Finally, TheStreet cut Sanofi from a “b” rating to a “c” rating in a report on Friday, February 9th. Three analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $55.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.